Fortis Healthcare News: Fortis Hospital Gurugram partners with Children’s Hospital Los Angeles (USA) for enhanced paediatric liver transpl

Gurugram, 20 December 2022: Fortis Memorial Research Institute, Gurugram has partnered with Children’s Hospital Los Angeles (CHLA) to enhance pediatric liver transplant facilities at Fortis Gurugram. Fortis Memorial Research Institute is the first hospital in Gurugram to collaborate with CHLA. The purpose of the collaboration is to seek second opinion for pediatric liver transplant patients, review of the medical records, diagnostics and to opine on the proposed treatment plan/alternate treatment modalities for pediatric patients who are being recommended a liver transplant. This partnership will also facilitate the patient’s family to get an independent opinion from a leading center in the United States while or prior being admitted at Fortis Gurugram. 

Mahipal Singh Bhanot, Senior Vice President & Business Head, Fortis Memorial Research Institute said, “We are happy to have collaborated with Children’s Hospital Los Angeles which is one of the world renowned hospitals for pediatric liver transplant. A team of doctors will be on the panel of CHLA to offer expert medical advice and treatment options. At Fortis Gurugram the Liver transplant team is spearheaded by Dr Vivek Vij, Chairman, Liver Transplant, Hepato-Pancreato-Biliary Surgery who has performed more than 32 pediatric liver transplants. Timely Diagnosis and treatment are the key factors for a successful liver transplant. In most of the cases when a patient is advised a major surgery, the patient’s family often wants to have a second opinion before going ahead with the surgery. The collaboration with CHLA will help the family get an independent opinion prior to the surgery/treatment.”

Dr. Rohit Kohli, MBBS, MS, Division Chief of Gastroenterology, Hepatology and Nutrition at Children’s Hospital Los Angeles CHLA said “Children’s Hospital Los Angeles is pleased to partner with Fortis Memorial Research Institute, India to provide pediatric liver failure patients with online second opinions courtesy of CHLA’s world-class medical experts. The Liver Transplant Program at CHLA, led by Surgical Director Yuri Genyk, MD, is one of the largest pediatric liver transplant programs in the United States, where close to 500 liver transplants have been performed in children since 1998. My team and I relish the opportunity to provide expert, compassionate guidance and support to patient families in India through this partnership.”

About Fortis Healthcare Limited  

“Fortis Healthcare Limited – an IHH Healthcare Berhad Company – is a leading integrated healthcare services provider in India. It is one of the largest healthcare organizations in the country with 27 healthcare facilities (including projects under development), 4100 operational beds and over 419 diagnostics centres (including JVs). Fortis is present in India, United Arab Emirates (UAE) & Sri Lanka. The Company is listed on the BSE Ltd and National Stock Exchange (NSE) of India. It draws strength from its partnership with global major and parent company, IHH, to build upon its culture of world-class patient care and superlative clinical excellence. Fortis employs 23,000 people (including SRL) who share its vision of becoming the world’s most trusted healthcare network. Fortis offers a full spectrum of integrated healthcare services ranging from clinics to quaternary care facilities and a wide range of ancillary services.”